Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Multiple studies have shown improvements in markers of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH) among patients treated with GLP-1 receptor agonists
GLP-1 receptor agonists mimic this hormone by binding to GLP-1 receptors throughout the body, including the pancreas, brain, stomach, and other organs
It works by mimicking a hormone in your body that helps control blood sugar, slows digestion, and reduces appetite
SURMOUNT-1 94% 0.06 [7] 2
US$ 20.54
US$ 28.75
US$ 29.70
US$ 22.25
US$ 29.83
US$ 28.37
